JP2016531895A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016531895A5 JP2016531895A5 JP2016520004A JP2016520004A JP2016531895A5 JP 2016531895 A5 JP2016531895 A5 JP 2016531895A5 JP 2016520004 A JP2016520004 A JP 2016520004A JP 2016520004 A JP2016520004 A JP 2016520004A JP 2016531895 A5 JP2016531895 A5 JP 2016531895A5
- Authority
- JP
- Japan
- Prior art keywords
- conjugate
- conjugate according
- patient
- polyethylene glycol
- peg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361887111P | 2013-10-04 | 2013-10-04 | |
| US61/887,111 | 2013-10-04 | ||
| PCT/US2014/059146 WO2015051307A1 (en) | 2013-10-04 | 2014-10-03 | Slow-release conjugates of sn-38 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019010029A Division JP6842479B2 (ja) | 2013-10-04 | 2019-01-24 | Ｓｎ−３８の徐放性コンジュゲート |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016531895A JP2016531895A (ja) | 2016-10-13 |
| JP2016531895A5 true JP2016531895A5 (enExample) | 2017-11-09 |
| JP6473145B2 JP6473145B2 (ja) | 2019-02-20 |
Family
ID=51871275
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016520004A Active JP6473145B2 (ja) | 2013-10-04 | 2014-10-03 | Ｓｎ−３８の徐放性コンジュゲート |
| JP2019010029A Active JP6842479B2 (ja) | 2013-10-04 | 2019-01-24 | Ｓｎ−３８の徐放性コンジュゲート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019010029A Active JP6842479B2 (ja) | 2013-10-04 | 2019-01-24 | Ｓｎ−３８の徐放性コンジュゲート |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10016411B2 (enExample) |
| EP (1) | EP3052101B1 (enExample) |
| JP (2) | JP6473145B2 (enExample) |
| KR (1) | KR102320753B1 (enExample) |
| CN (1) | CN106061483B (enExample) |
| AU (2) | AU2014331591B2 (enExample) |
| BR (1) | BR112016007410B1 (enExample) |
| CA (1) | CA2925132C (enExample) |
| DK (1) | DK3052101T3 (enExample) |
| ES (1) | ES2759905T3 (enExample) |
| MX (1) | MX371201B (enExample) |
| SG (2) | SG11201602258WA (enExample) |
| TW (1) | TWI716342B (enExample) |
| WO (1) | WO2015051307A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106061483B (zh) * | 2013-10-04 | 2021-01-08 | 普洛林克斯有限责任公司 | Sn-38的缓释结合物 |
| CN107375288B (zh) | 2016-05-16 | 2019-08-23 | 博瑞生物医药（苏州）股份有限公司 | 多臂的聚合靶向抗癌偶联物 |
| KR102279429B1 (ko) | 2017-04-21 | 2021-07-20 | 브라이트제네 바이오-메디컬 테크놀로지 코., 엘티디. | 멀티 암 표적 항암 콘쥬게이트 |
| JP2021510702A (ja) * | 2018-01-12 | 2021-04-30 | プロリンクス エルエルシー | 相乗的がん治療 |
| EP3852793B1 (en) | 2018-09-17 | 2025-11-19 | The Children's Hospital Of Philadelphia | Macromolecular prodrug peg-[sn22]4 |
| MX2021011997A (es) | 2019-04-05 | 2021-11-04 | Prolynx Llc | Enlazadores de conjugacion mejorados. |
| WO2020219943A1 (en) | 2019-04-26 | 2020-10-29 | Prolynx Llc | Slow-release cytokine conjugates |
| US12472261B2 (en) | 2019-08-28 | 2025-11-18 | Prolynx Llc | Conjugated inhibitors of DNA damage response |
| JP2023537247A (ja) * | 2020-07-28 | 2023-08-31 | チョンチン、アップグラ、バイオテクノロジー、カンパニー、リミテッド | ポリエチレングリコール複合薬、ならびにその調製方法およびその使用 |
| ES3010582T3 (en) | 2020-09-28 | 2025-04-03 | Fundacio Inst De Recerca Biomedica Irb Barcelona | Peptidic conjugates of sn38 useful in the treatment of cancer |
| US11976196B2 (en) * | 2021-04-14 | 2024-05-07 | Cambridge Crops, Inc. | Silk packaging applications |
| IL315988A (en) | 2022-03-28 | 2024-11-01 | Sant Joan De Deu Hospital | Peptidic water-soluble delivery system of anticancer drugs |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6011042A (en) * | 1997-10-10 | 2000-01-04 | Enzon, Inc. | Acyl polymeric derivatives of aromatic hydroxyl-containing compounds |
| AU2003253890A1 (en) * | 2002-07-12 | 2004-02-02 | Biomarin Pharmaceutical Inc. | The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates |
| CA2502870C (en) | 2002-10-31 | 2011-07-26 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight derivatives of camptothecins |
| US20040247624A1 (en) * | 2003-06-05 | 2004-12-09 | Unger Evan Charles | Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
| CN1852740B (zh) * | 2003-09-17 | 2011-05-11 | 耐科塔医药公司 | 多支链聚合物的药物前体 |
| US7462627B2 (en) | 2006-02-09 | 2008-12-09 | Enzon Pharmaceuticals, Inc. | Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers |
| MX2009002855A (es) * | 2006-09-15 | 2009-03-30 | Enzon Pharmaceuticals Inc | Profarmacos polimericos dirigidos que contienen enlazadores multifuncionales. |
| US20100098654A1 (en) * | 2008-10-21 | 2010-04-22 | Fabio Pastorino | Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| EP2366105A1 (en) | 2008-11-18 | 2011-09-21 | Baxter International Inc. | Methods of determining polydispersity and/or molecular weight distribution of a polyethylene glycol sample |
| JP2012528240A (ja) | 2009-05-28 | 2012-11-12 | メルサナ セラピューティックス， インコーポレイテッド | 可変速度放出リンカーを含むポリアル−薬物コンジュゲート |
| CA2780645C (en) * | 2009-11-18 | 2018-01-16 | Nektar Therapeutics | Salt form of a multi-arm polymer-drug conjugate |
| WO2011140376A1 (en) * | 2010-05-05 | 2011-11-10 | Prolynx Llc | Controlled drug release from dendrimers |
| WO2011140393A1 (en) | 2010-05-05 | 2011-11-10 | Prolynx Llc | Controlled release from macromolecular conjugates |
| JP2012000072A (ja) * | 2010-06-18 | 2012-01-05 | Japan Health Science Foundation | 新規な抗フィブリン抗体 |
| TW201215412A (en) * | 2010-08-30 | 2012-04-16 | Sun Pharma Advanced Res Co Ltd | Stable pharmaceutical composition |
| WO2012088282A1 (en) * | 2010-12-21 | 2012-06-28 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds |
| WO2013036857A1 (en) * | 2011-09-07 | 2013-03-14 | Prolynx Llc | Sulfone linkers |
| CN106061483B (zh) * | 2013-10-04 | 2021-01-08 | 普洛林克斯有限责任公司 | Sn-38的缓释结合物 |
-
2014
- 2014-10-03 CN CN201480062543.4A patent/CN106061483B/zh active Active
- 2014-10-03 KR KR1020167011936A patent/KR102320753B1/ko active Active
- 2014-10-03 DK DK14796322.7T patent/DK3052101T3/da active
- 2014-10-03 SG SG11201602258WA patent/SG11201602258WA/en unknown
- 2014-10-03 TW TW103134678A patent/TWI716342B/zh active
- 2014-10-03 EP EP14796322.7A patent/EP3052101B1/en active Active
- 2014-10-03 AU AU2014331591A patent/AU2014331591B2/en active Active
- 2014-10-03 BR BR112016007410-6A patent/BR112016007410B1/pt active IP Right Grant
- 2014-10-03 CA CA2925132A patent/CA2925132C/en active Active
- 2014-10-03 WO PCT/US2014/059146 patent/WO2015051307A1/en not_active Ceased
- 2014-10-03 SG SG10201811365RA patent/SG10201811365RA/en unknown
- 2014-10-03 MX MX2016004299A patent/MX371201B/es active IP Right Grant
- 2014-10-03 ES ES14796322T patent/ES2759905T3/es active Active
- 2014-10-03 US US15/026,579 patent/US10016411B2/en active Active
- 2014-10-03 JP JP2016520004A patent/JP6473145B2/ja active Active
-
2018
- 2018-06-14 US US16/009,078 patent/US10342792B2/en active Active
- 2018-11-01 AU AU2018256608A patent/AU2018256608A1/en not_active Abandoned
-
2019
- 2019-01-24 JP JP2019010029A patent/JP6842479B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Anderluzzi et al. | The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency | |
| JP2018528184A5 (enExample) | ||
| SG11201908101YA (en) | Hepatitis b virus surface antigen inhibitor | |
| HRP20141258T1 (hr) | 6-amino-2-{[(1s)-1-metilbutil]oksi}-9-[5-(1-piperidinil)pentil]-7,9-dihidro-8h-purin-8-on maleat | |
| RU2018105655A (ru) | Комбинированная терапия с применением липосомального иринотекана и ингибитора parp для лечения рака | |
| JP2013510120A5 (enExample) | ||
| HRP20170433T1 (hr) | Pripravci spoja za izmjenu lipidiranog imunološkog odgovora, formulacije, i postupci | |
| JP2016506916A5 (enExample) | ||
| JP2013510123A5 (enExample) | ||
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| JP2010270124A5 (enExample) | ||
| JP2013534248A5 (enExample) | ||
| WO2009095226A3 (en) | NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS | |
| EP3356355B1 (en) | Compounds and combinations for the treatment of hiv | |
| JP2016516074A5 (enExample) | ||
| RU2013104401A (ru) | Фармацевтический препарат, содержащий ингибитор фосфодиэстеразы | |
| JP2017525718A5 (enExample) | ||
| RU2017112308A (ru) | Композиции и способы для лечения бессонницы | |
| JP2017513809A5 (enExample) | ||
| JP2019515908A5 (enExample) | ||
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| JP2015522033A5 (enExample) | ||
| JP2015520196A5 (enExample) | ||
| JP2012503602A5 (enExample) | ||
| JP2017532316A5 (enExample) |